6 episodi
The ASCVD Pubcast medthority
-
- Istruzione
This content has been developed independently of the sponsor, Novartis Pharma AG, who has had no editorial input into the content. Medthority received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
All opinions expressed in the publication digest podcast series are those of the invited faculty. This content should not be taken as medical advice and is for informational purposes only. Please consult your regional clinical practice guidelines for clinical practice recommendations in your area.
Join our expert faculty, Professor Stephen Nicholls, Professor Kausik Ray and Professor Oliver Weingärtner as they discuss recent publications in the context of ASCVD and how these findings can be incorporated into clinical practice.
This podcast is intended for Healthcare Professionals only. Please be aware this content is not intended for US based audiences.
-
Episode 6: The ORION-8 trial and ASCVD
Professor Stephen Nicholls and Professor Alberico Catapano discuss the ORION-8 phase 3 clinical trial and analyse its implications for ASCVD management and ongoing research.
-
Episode 5: ASCVD and the SANTORINI study
Professor Alberico Catapano joins Professor Stephen Nicholls to discuss the SANTORINI study exploring gaps and unmet needs in ASCVD and how they impact clinical practice. Professor Catapano emphasises the pivotal role of the SANTORINI study in improving clinical practice by providing additional data to guide clinicians in LDL-C reduction in medium to high-risk individuals with ASCVD.
-
Episode 4: ASCVD and CLEAR Outcomes
Listen to Professor Stephen Nicholls and Professor Kausik Ray discuss the results of the bempedoic acid cardiovascular efficacy trial, CLEAR Outcomes. Hear about the ethical considerations in this population of patients who cannot tolerate statins and why the findings are also good news for those beyond this specific subgroup.
-
Episode 3: Lipoprotein(a) in ASCVD
Professor Oliver Weingärtner is joined by Professor Stephen Nicholls to discuss the relationship between lipoprotein(a) and the association with atherosclerotic cardiovascular disease and aortic stenosis. Take a deep dive into the European Atherosclerosis Societies Consensus Statement and what it means for patients with ASCVD.
-
Episode 2: ASCVD and the ORION-10 and ORION-11 trials
Professor Kausik Ray joins Professor Stephen Nicholls to discuss the two Phase 3 clinical trials, ORION 10 and 11; studies exploring gaps and unmet needs in the management of ASCVD and how they impact clinical practice.
-
Episode 1: ASCVD and the DA VINCI study
Join Professor Stephen Nicholls and Professor Kausik Ray as they discuss the implications of the DA VINCI study on patients with ASCVD across Europe. This podcast takes a deep dive into the EU-wide cross-sectional study into the use of lipid-modifying therapies used in primary and secondary care.